Zealand Pharma A/S, a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced the interim report for the six months ended June 30, 2023 and provided a corporate update.
Zealand Pharma A/S, a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced the interim report for the six months ended June 30, 2023 and provided a corporate update.